We are beyond excited to announce that Kelvin Health just signed a non-dilutive grant funding agreement for state support amounting to $2.9M! The financing will be utilized through the course of two consecutive years and will boost the R&D, regulatory, and early market access activities of the company. The news are coming shortly after Kelvin Health graduated from the reputable MedTech Innovator US market access program in Jun-Nov this year. We are on a mission to prevent complications from conditions like artery disease thanks to accessible early diagnostics. This also contributes to earlier detection of changes in the overall vascular status of the patient.It's inspiring the have the support of our country, which unfortunately is still among the leading ones in terms of cardiovascular disease prevalence and mortality. Something that we are definitely going to change!